Literature DB >> 3271001

Buspirone hydrochloride in the treatment of transvestic fetishism.

J P Fedoroff1.   

Abstract

The author presents a case report of a 46-year-old man with generalized anxiety disorder and transvestic fetishism who responded to treatment with buspirone. The patient stopped cross-dressing while taking buspirone, but alprazolam had no effect on the frequency of cross-dressing. The author discusses the implications of using buspirone in the treatment of both inhibited sexual desire and transvestic fetishism.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3271001

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

2.  The Relation Between the Paraphilias and Anxiety in Men: A Case-Control Study.

Authors:  Mélanie H Fox; Michael C Seto; Nabhan Refaie; Sofija Lavrinsek; Victoria Hall; Susan Curry; Andrea R Ashbaugh; Enya Levaque; J Paul Fedoroff; John M Bradford; Martin L Lalumière
Journal:  Arch Sex Behav       Date:  2022-10-06

3.  Buspirone hydrochloride in the treatment of an atypical paraphilia.

Authors:  J P Fedoroff
Journal:  Arch Sex Behav       Date:  1992-08

Review 4.  Epidemiologic and clinical updates on impulse control disorders: a critical review.

Authors:  Bernardo Dell'Osso; A Carlo Altamura; Andrea Allen; Donatella Marazziti; Eric Hollander
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-07       Impact factor: 5.270

5.  Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Authors:  Donatella Marazziti; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-05-22

6.  Treatment of transvestic fetishism with fluoxetine: a case report.

Authors:  Mohammad Amir Usmani; Rakesh K Gaur; Suhail Ahmad Azmi; Sheshank Gangwar
Journal:  Iran J Psychiatry Behav Sci       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.